Characteristic | Diabetes (n = 34) | No diabetes (n = 96) | P |
---|---|---|---|
Men/women | 25 (74)/9 (26) | 86 (90)/10 (10) | <0.05 |
Age (y) | 62 ± 9 | 60 ± 9 | NS |
CCS angina class | 2.5 ± 0.9 | 2.2 ± 1.0 | NS |
NYHA functional class | 2.7 ± 1.1 | 2.6 ± 1.1 | NS |
Previous myocardial infarction | 32 (94) | 91 (95) | NS |
Q wave myocardial infarction | 26 (76) | 74 (77) | NS |
Anterior myocardial infarction | 17 (50) | 48 (50) | NS |
Family history of coronary disease | 20 (59) | 58 (60) | NS |
Hypercholesterolemia | 16 (47) | 41 (43) | NS |
Smoking, current/prior | 9 (26)/15 (44) | 34 (35)/37 (39) | NS |
Systemic hypertension | 24 (71) | 69 (72) | NS |
Stenosed coronary arteries | 2.6 ± 0.7 | 2.5 ± 0.6 | NS |
LVEF (%) | 31 ± 10 | 33 ± 10 | NS |
Baseline plasma glucose (mmol/L) | 11 ± 3 | 5 ± 0.8 | <0.01 |
Medical therapy | |||
Insulin | 12 (35) | ||
Oral antidiabetic medication | 27 (79) | ||
ACE inhibitors | 25 (74) | 62 (65) | NS |
Aspirin/anticoagulation | 27 (79) | 89 (93) | NS |
β-Blockers | 16 (44) | 65 (68) | NS |
Digoxin | 8 (24) | 20 (21) | NS |
Diuretics | 22 (65) | 38 (40) | NS |
Nitrates | 27 (79) | 73 (76) | NS |
Statins | 15 (44) | 50 (52) | NS |
Data are mean ± SD or number of patients, with percentages in parentheses. ACE = angiotensin-converting enzyme; CCS = Canadian Cardiovascular Society; NS = not statistically significant; NYHA = New York Heart Association.